Spotlight
- China: Gaining Entry
-
Pharmaceutical companies in a fierce race to bring their products to market have begun to regard economically burgeoning China as an R&D paradise.
- French Biotech: In Pursuit of Funding
-
With government funding in limited supply, biotech companies in France have developed strategies to build financial muscle and ensure their economic vision for the future.
- India's Road to Success
-
India is establishing itself as a global leader for pharmaceutical research, and increasingly, commercialization.
- HIV/AIDS in South Africa: Progress Through Collaboration
-
As South Africa grapples with the world’s largest population suffering with HIV/AIDS, pharmaceutical manufacturers and non-government organizations are working together to fight the pandemic and search for a cure.
- The Path to Collaboration
-
The initial projects of the Critical Path Initiative are helping to build a foundation for more modernized drug development.
- A Window of Opportunity
-
The cooperative efforts of government agencies, pharmaceutical manufacturers and academic researchers are helping to modernize Japan’s drug development climate.
- Adaptive Design: In Theory and Practice
-
Adaptive trial design has the potential to reduce costs, save time and enable greater patient safety … but only if thoroughly planned and properly executed.
- Navigating Rocky Terrain
-
Many clinical trial sponsors are heading to Latin America—but there are still plenty of obstacles to overcome.
Web Exclusives
- Statistical Advantage
-
Gary Shorter, director of biostatistics for Quintiles, talks to Envisage editor Adam Istas about the growing importance of incorporating biostatistical analysis into all stages of drug development.
- Measure for Measure
-
A proposed Health Care Comparative Effectiveness Research Institute in the United States may force the biopharmaceutical industry to emphasize patient outcomes and quality of life issues when developing a new medicinal product.